DOI: 10.4244/EIJV13I17A326

May in Paris! Join us! EuroPCR 2018

Michael Haude, MD, President EAPCI

With the year progressing quickly and May soon upon us, I want to take this opportunity to invite you all – if you haven’t made your plans already – to join us at the official scientific meeting of the EAPCI, EuroPCR, which will be taking place at the Palais des Congrès in Paris from 22 to 25 May.

There is little to add that is not already universally acknowledged about this dynamic and trend-setting Course. It has become an indispensable annual rendezvous for all our profession, a point in time and space when all the different aspects and concerns of our speciality intersect, a privileged moment openly and freely to exchange with our peers the latest news and, more importantly, the latest insights into how we practise interventional medicine today. EuroPCR is the theatre for a vast number of activities that take place each year – from the annual meeting of our association (this year witnessing the changing of Presidents, but more about that next month) to the training sessions and hands-on demonstrations of technique, to the live case broadcasts from leading centres throughout the world… I could go on, but I think we are all aware of the dimensions of the official scientific meeting of our association and why we should all participate.

The Course is never a static affair and each year holds its special surprises. Some are due to evolutions in our devices, or insights into the care we offer or the healthcare systems in which we work. Others reflect our expanding knowledge in such topics as valvular therapy or ischaemic stroke or, as last year, an opportunity to explore the history of our profession.

In 2017, we didn’t just celebrate the 40 years of PCI, but began what we feel is a major evolution in the type of education we offer to Fellows. At the initiative of the EAPCI’s New Initiatives For Young Interventionists Committee, the EAPCI Fellows Course, which had previously taken place outside of the EuroPCR meeting, became an integral part of EuroPCR itself. This change in timing and the subsequent integration within the meeting brought with it numerous possibilities, allowing specially focused sessions designed by and for the young specialists and permitting us to highlight which sessions and symposiums during the main programme were relevant for these Fellows.

We must never forget that our ultimate goal in improving medical care for all requires the highest level of education, outreach and the ability to create – and sustain – communities. To do this, we need to have a high level of coordination, confidence and trust among all the different players involved in providing healthcare today. Nurses and allied health professionals, engineers developing new and innovative devices, government regulatory bodies and national societies along with our industry partners all play a concerted part in the success of the whole.

One of the aspects that makes a Course such as EuroPCR accessible and sustainable is financing. An example of this can be seen in the activities of the Fellows Course which received generous educational grants provided by industry sponsors. This year, independent funding by industry has evolved, becoming more transparent and continuing as an ethical process. MedTech Europe, the official trade association that represents the European medical technology industry remains “fully committed to support independent medical education” and has developed a code of practice, which took effect on 1 January to govern their relationship to CME, allowing them to “safeguard and protect” their “relationship with healthcare professionals by adopting a clear and strict self-regulation… through independent third-parties”. EuroPCR and the EAPCI are such parties, and are pleased to continue in our traditional role of providing information – and education – to any and all of our members.

Working together, the EAPCI is proud of the success and evolution of EuroPCR and the quality of the education we can offer. The success of individual aspects of our work, like the Fellows programme, underlines what we can accomplish by committing ourselves to a free exchange of experience and ideas. The actions of our association and the work of the Course support the sharing of clinical knowledge, provide a foundation for innovation and offer opportunities for advancement in the practice of our speciality for all those wishing to participate – whether a student, a young fellow beginning their professional career, or the more accomplished specialists and healthcare providers among us.

Volume 13 Number 17
Apr 20, 2018
Volume 13 Number 17
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I1A6 May 20, 2014
May 2014, a very special month
Fajadet J
free

10.4244/EIJV9I1A6 May 21, 2013
Sharing and growing together: EuroPCR 2013
Fajadet J
free

10.4244/EIJV7I8A142 Dec 30, 2011
Rayonnement…
Fajadet J
free

10.4244/EIJV11I3A50 Jul 20, 2015
Notes from the EAPCI general assembly
Windecker S
free

EAPCI Column

May 16, 2025
EAPCI at EuroPCR 2025
free

10.4244/EIJV10I3A52 Jul 21, 2014
Sustained progress through continuity: a new presidential criss-cross
Windecker S
free

10.4244/EIJV7I2A29 Jun 30, 2011
EuroPCR 2011: the ongoing challenge of initiatives and innovations
Serruys PW
free

10.4244/EIJV8I5A83 Sep 28, 2012
The “Valve” Season is upon us
Fajadet J
free
Trending articles
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
73.05

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved